In episode 9 - a short week for the FDA, we talk about approval of Liletta for pregnancy prevention up to 6 years, Vumerity was approved for multiple sclerosis (MS), and added indication for Baxdela. We also give a brief update on new biosimilars expected in the next few months, and a new recall on alprazolam.